Precision targeting of the SASP in cancer therapy

Key Points

• Modulating the senescence-associated secretory phenotype (SASP) enhances cancer therapy outcomes, indicating a promising path for treatment.
• Significant reduction in inflammatory cytokines was observed during targeted interventions, highlighting a key effect of modulation.
• Preclinical analyses involving various cancer models support the effectiveness of SASP targeting in tumor treatment approaches.
• Targeting the SASP may drive future precision therapies, emphasizing the need for further validation in broader contexts.